A detailed history of Prudential PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prudential PLC holds 6,310 shares of AZN stock, worth $423,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,310
Previous 6,410 1.56%
Holding current value
$423,905
Previous $499,000 1.6%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $7,667 - $8,762
-100 Reduced 1.56%
6,310 $491,000
Q2 2024

Aug 06, 2024

BUY
$66.81 - $80.83 $107,564 - $130,136
1,610 Added 33.54%
6,410 $499,000
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $39,059 - $44,524
-640 Reduced 11.76%
4,800 $325,000
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $336,681 - $376,883
5,440 New
5,440 $366,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.